Biotech Essentials

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 01.06.2021.

Medicine
Drug
Human respiratory syncytial virus
Pharmacology
Clinical research
Rheumatology

Healthcare

@WSJhealth shared
On May 28, 2021
RT @jonathanrockoff: BREAKING: For decades, scientists struggled to find a medicine that could treat one of the most common cancer mutations. Amgen has won approval from U.S. health regulators for the first drug targeting the KRAS mutation, ⁦@joewalkerWSJ⁩ reports. https://t.co/QdmdA0uSdJ
Open
Amgen Wins Approval for Pathbreaking Lung Cancer Drug

Amgen Wins Approval for Pathbreaking Lung Cancer Drug

A potential blockbuster, the drug is the first to treat a common cancer mutation called KRAS that researchers struggled for years to target.

@ldtimmerman shared
On May 27, 2021
11 Asian American Execs Shaping the Future of Biopharma. By @jingyiliu8 and @EricDai_BioE #AsianPacificAmericanHeritageMonth https://t.co/qNJhpKJuPM
Open
11 Asian-American Executives Shaping the Future of Biopharma

11 Asian-American Executives Shaping the Future of Biopharma

The biopharma industry was pressured to get faster and more innovative to respond to the urgent global health challenge of the past year. Asian-American executives have played a key role in ...

@BIODeutschland shared
On May 28, 2021
BRAIN Biotech AG H1 ‘20/’21 Results https://t.co/2iSkSBE6x1
Open
BRAIN Biotech AG H1 ‘20/’21 Results

BRAIN Biotech AG H1 ‘20/’21 Results

We are a specialist in industrial biotechnology. With our innovative bio-based products and solutions, we contribute to value creation – from concept to production and beyond. We rely on ...

@Biotechnology shared
On May 28, 2021
FDA Lays Out Roadmap to Clear Inspection Backlog as Biomanufacturing Booms https://t.co/fi55cq30jM https://t.co/oGX8C6odPT
Open
FDA Lays Out Roadmap to Clear Inspection Backlog as Biomanufacturing Booms

FDA Lays Out Roadmap to Clear Inspection Backlog as Biomanufacturing Booms

The FDA has a massive backlog of site inspections due to the pandemic. To address the problem, the agency made its Resiliency Roadmap outlining its priorities.

@BIODeutschland shared
On May 26, 2021
PL Bioscience https://t.co/DBbCBcgzO2
Open
INVESTMENT OF 3.7 MLN EURO FOR PL BIOSCIENCE

INVESTMENT OF 3.7 MLN EURO FOR PL BIOSCIENCE

Closing of our investment round We are glad to have convinced a group of renowned life science-experienced investors of our mission We are excited to announce that Brightlands …

@BIODeutschland shared
On May 28, 2021
Bavarian Biotech News May 2021 https://t.co/b6Fjpiqzyt
Open
PowerPoint-Präsentation

PowerPoint-Präsentation

Bavarian Biotech News May 2021 SPOTLIGHT COVID-19 Page 3 RECENT HEADLINES Page 4 - 6 BIOENTREPRENEURS IN BAVARIA Page 7 BAVARIA INTERNATIONAL Page 8 EVENTS & CONTACT Page 9 DEAR …

@GalapagosGlobal shared
On May 27, 2021
We are pleased to announce that we will be attending the @EULAR_org European Rheumatology Congress, EULAR 2021 to present data and insights. Read our press release here: https://t.co/0ZuDacKMNW #EULAR2021 #EULAR #Rheumatology https://t.co/FwbfLFY1xp
Open
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress

Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress

Mechelen, Belgium, 27 May 2021, 22:01 CET, – Galapagos NV (Euronext & Nasdaq: GLPG) today announced that 15 abstracts, including scientific updates,...

@JaredSHopkins shared
On May 25, 2021
For sure, there are many great stories about the NIH's @BarneyGrahamMD and the role his lab has played in understanding the new coronavirus and Covid-19 vaccine development https://t.co/XuXXNsgFh9 https://t.co/zDq4VlRVXA https://t.co/vszvvjo1g0
Open
Deliver a safe, effective COVID-19 vaccine in less than a year? Impossible. Meet Moncef Slaoui.

Deliver a safe, effective COVID-19 vaccine in less than a year? Impossible. Meet Moncef Slaoui.

Credit for Moderna's COVID-19 vaccine belongs in part to discoveries dating back 15 years. The team behind it was inspired by two infant deaths.